Forte Biosciences, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
FBRX on Nasdaq
Location
3060 Pegasus Park Drive, Building 6, Dallas, TX

Insiders trading volume in the past year

Forte Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul A. Wagner CEO, Secretary and Chair of the Board, Director $406K +$71.8K +21.5% Oct 1, 2024
Antony A. Riley Chief Financial Officer $188K +$125K +198% Nov 21, 2024
Hubert C. Chen President and Chief Scientific Officer $151K Jan 1, 2024
Donald Williams Director Aug 20, 2024
Stephen K. Doberstein Director Aug 20, 2024
Steven Kornfeld Director Aug 20, 2024
Lawrence Eichenfield Director Aug 20, 2024
Barbara K. Finck Director Aug 20, 2024
Scott C. Brun Director Aug 20, 2024
Shivpreet Singh Kapoor Director Sep 17, 2024
David W. Gryska Director Aug 20, 2024
Richard G. Vincent Director Sep 17, 2024
Patricia S. Walker Director Jun 1, 2022

Recent Insider Transactions by Companies or Individuals for Forte Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.